Mesa Labs outlines fiscal 2027 revenue of $250M-$255M and adjusted EBITDA of $66M-$68M as it authorizes $40M buyback

Earnings Call Insights: Mesa Laboratories (MLAB) Q2 fiscal 2027

Management View

• “For fiscal 2027, we expect revenues of $250 million to $255 million and adjusted EBITDA of $66 million to $68 million.” (CEO, President & Director Siddhartha Kadia)
• “Organic revenues

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.